Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
about
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesCell biology. Metabolic control of cell deathAutophagy protects against palmitate-induced apoptosis in hepatocytesSignaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cellsMechanisms of lipotoxicity in NAFLD and clinical implicationsResveratrol enhances palmitate-induced ER stress and apoptosis in cancer cellscAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinaseMechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosisToyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway.Cysteine aggravates palmitate-induced cell death in hepatocytes.PUMA, a critical mediator of cell death--one decade on from its discovery.Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning.Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors.Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.Involvement of endoplasmic reticulum stress in all-trans-retinal-induced retinal pigment epithelium degeneration.Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosisHepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis.Who pulls the trigger: JNK activation in liver lipotoxicity?Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis.HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity.To die or not to die: death signaling in nonalcoholic fatty liver disease.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q28392033-7A4CB396-11A4-4385-945B-BB1260AA4930Q28397089-BCB0B444-F1E8-478B-94A5-2DB6AECD8ABBQ33712340-8AE76F84-1ADB-4AFF-BCDA-EC25480A70A1Q34557052-F77DD741-41F3-40A1-B526-BA9689E93C23Q35132916-3D2E2902-8D0F-4222-BED9-6135FF938A69Q35462357-B0D81EAF-12D4-4DF7-B824-6949F9AA990DQ35760713-384641EE-EC84-4EE2-9E01-D0F422AB5C8EQ35939383-8D429D4A-EEFC-4884-B0EF-7C6F2A91EB54Q36302806-4D891800-A326-46D6-BB9C-62FDEBD9CCCEQ36335609-F8C967A3-CFE0-462F-8784-5F49B353047CQ36781204-6B2F096A-2EEB-4C2A-A396-ECCEB61F3441Q37454201-2E67A5B1-607F-43F7-B60D-D1ED90A66F5AQ37726495-FC6B1D4B-E77E-4D03-BA31-011C54B590E6Q38045794-6B34B914-1896-44D4-B460-BFB8C6508C14Q38085856-9E0FF802-17F3-4FD7-B4D7-7CE0F6E5C926Q38594016-A94AEB8D-A9FE-4E5D-84FB-03F3687EABA9Q38747634-E7EA9B0D-72D3-4416-A720-1E7BB398297CQ38759104-E7FBB530-687F-4351-B097-518A6644C6C3Q38911401-B2A5EBCE-7211-4133-B6A6-908EC27F3B03Q38946467-12B2881C-06A0-4EA7-B7CC-F64BF3EF40CAQ39000961-E6268395-54D6-4A0D-B4DE-80DA6B0469C5Q41867049-92939E8C-3DFA-4BC7-96C3-7B343F2CE556Q42592098-347D806E-CD5C-435C-A296-281DB219494AQ46171319-6C014D40-FF33-4900-83A9-948E2B796E3BQ51132126-2530D52D-CFE2-4E17-B123-5F4591ECEEACQ51760102-FA1C31F3-56FA-42AA-8BE7-55B0FF401D1CQ54119547-193CD790-9082-497C-B22F-19DBA6EE357EQ55503094-E2BD0536-4652-4C60-9BE9-C5B5B6AA4139
P2860
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
@en
Glycogen synthase kinase-3
@nl
type
label
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
@en
Glycogen synthase kinase-3
@nl
prefLabel
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
@en
Glycogen synthase kinase-3
@nl
P2093
P2860
P1476
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
@en
P2093
Daniel D Billadeau
Nafisa A Elmi
Nathan W Werneburg
Samar H Ibrahim
Sophie C Cazanave
Steven F Bronk
Yuko Akazawa
P2860
P304
P356
10.1016/J.JHEP.2010.09.039
P577
2010-11-23T00:00:00Z